EUVIMEDEUVIMED entdecken
Open Access

Intracutaneous Transplantation of Islets Within a Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation

Darling Rojas-Canales, Stacey N Walters, Daniella Penko, Daniele Cultrone, Jacqueline Bailey, Tatyana Chtanova, Jodie Nitschke, Julie Johnston, Svjetlana Kireta, Thomas Loudovaris, Thomas W Kay iD, Tim R Kuchel und 7 weitere

Diabetes · 2023

DOI: 10.2337/db21-0841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Darling Rojas-Canales und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Adelaide, Royal Adelaide Hospital Campus, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Islets of Langerhans, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hospital Research Foundation, Juvenile Diabetes Research Foundation International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic islet transplantation for type 1 diabetes is limited by the need for multiple infusions and poor islet viability posttransplantation. The development of alternative transplantation sites is necessary to improve islet survival and facilitate monitoring and retrieval. We tested a clinically proven biodegradable temporizing matrix (BTM), a polyurethane-based scaffold, to generate a well-vascularized intracutaneous “neodermis” within the skin for islet transplantation. In murine models, BTM did not impair syngeneic islet renal-subcapsular transplant viability or function, and it facilitated diabetes cure for over 150 days. Furthermore, BTM supported functional neonatal porcine islet transplants into RAG-1−/− mice for 400 days. Hence, BTM is nontoxic for islets. Two-photon intravital imaging used to map vessel growth through time identified dense vascular networks, with significant collagen deposition and increases in vessel mass up to 30 days after BTM implantation. In a preclinical porcine skin model, BTM implants created a highly vascularized intracutaneous site by day 7 postimplantation. When syngeneic neonatal porcine islets were transplanted intracutaneously, the islets remained differentiated as insulin-producing cells, maintained normal islet architecture, secreted c-peptide, and survived for over 100 days. Here, we show that BTM facilitates formation of an islet-supportive intracutaneous neodermis in a porcine preclinical model, as an alternative islet-transplant site. Article Highlights Human and porcine pancreatic islets were transplanted into a fully vascularized biodegradable temporizing matrix (Novosorb) that creates a unique intracutaneous site outside of the liver in a large-animal preclinical model. The intracutaneous prevascularized site supported pancreatic islet survival for 3 months in a syngeneic porcine-transplant model. Pancreatic (human and porcine) islet survival and function were demonstrated in an intracutaneous site outside of the liver for the first time in a large-animal preclinical model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of Langerhans TransplantationIslets of LangerhansDiabetes Mellitus, Type 1SwineHumansAnimalsMiceGraft SurvivalCollagen

Substanzen

Collagen

Autor:innen und Institutionen

  • Department of Medicine, University of Adelaide, Royal Adelaide Hospital Campus, Adelaide, South Australia, Australia.
  • Central Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Transplantation Immunology Laboratory, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • St. Vincent's Institute, Melbourne, Victoria, Australia.
  • South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

ORCID-Profile: Thomas W Kay, Philip J O'Connell, Shane T Grey, P Toby Coates

Förderung

  • Hospital Research Foundation
  • Juvenile Diabetes Research Foundation International

Zitieren

APA

Rojas-Canales, D., Walters, S. N., Penko, D., Cultrone, D., Bailey, J., Chtanova, T., Nitschke, J., Johnston, J., Kireta, S., Loudovaris, T., Kay, T. W., Kuchel, T. R., Hawthorne, W., O'Connell, P. J., Korbutt, G., Greenwood, J. E., Grey, S. T., Drogemuller, C. J., & Coates, P. T. (2023). Intracutaneous Transplantation of Islets Within a Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation. Diabetes. https://doi.org/10.2337/db21-0841

Vancouver

Rojas-Canales D, Walters SN, Penko D, Cultrone D, Bailey J, Chtanova T, et al. Intracutaneous Transplantation of Islets Within a Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation. Diabetes. 2023. doi:10.2337/db21-0841

BibTeX
@article{RojasCanales2023,
  author = {Rojas-Canales, Darling and Walters, Stacey N and Penko, Daniella and Cultrone, Daniele and Bailey, Jacqueline and Chtanova, Tatyana and Nitschke, Jodie and Johnston, Julie and Kireta, Svjetlana and Loudovaris, Thomas and Kay, Thomas W and Kuchel, Tim R and Hawthorne, Wayne and O'Connell, Philip J and Korbutt, Greg and Greenwood, John E and Grey, Shane T and Drogemuller, Chris J and Coates, P Toby},
  title = {Intracutaneous Transplantation of Islets Within a Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation},
  journal = {Diabetes},
  year = {2023},
  doi = {10.2337/db21-0841}
}
Kostenlos starten →